Hemochromatosis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hemochromatosis}} | {{Hemochromatosis}} | ||
{{CMG}}; {{AE}}{{SKA}} | {{CMG}} {{shyam}}; {{AE}}{{SKA}} | ||
==Overview== | ==Overview== | ||
| Line 8: | Line 8: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Hemochromatosis can be prevented secondarily by:<ref name="pmid11917720">{{cite journal| author=de Souza AF, Carvalho-Filho RJ, Chebli JF| title=[Hereditary hemochromatosis. Case report and review of the literature]. | journal=Arq Gastroenterol | year= 2001 | volume= 38 | issue= 3 | pages= 194-202 | pmid=11917720 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11917720 }}</ref><ref name="pmid18333157">{{cite journal| author=Kew MC| title=Prevention of hepatocellular carcinoma. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 1 | pages= 16-25 | pmid=18333157 | doi=10.1080/13651820410024030 | pmc=2023918 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333157 }}</ref> | Hemochromatosis can be prevented secondarily by:<ref name="pmid11917720">{{cite journal| author=de Souza AF, Carvalho-Filho RJ, Chebli JF| title=[Hereditary hemochromatosis. Case report and review of the literature]. | journal=Arq Gastroenterol | year= 2001 | volume= 38 | issue= 3 | pages= 194-202 | pmid=11917720 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11917720 }}</ref><ref name="pmid18333157">{{cite journal| author=Kew MC| title=Prevention of hepatocellular carcinoma. | journal=HPB (Oxford) | year= 2005 | volume= 7 | issue= 1 | pages= 16-25 | pmid=18333157 | doi=10.1080/13651820410024030 | pmc=2023918 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18333157 }}</ref> | ||
* Dietary modifications | * '''Dietary modifications''': This includes avoidance of excess vitamin C, red meat, iron supplements, and alcohol. | ||
* Phlebotomy | * '''Phlebotomy''': This can be done routinely, typically once every few weeks or months, to prevent iron accumulation. | ||
* '''Iron chelation therapy''': The use of iron chelators is not common for hemochromatosis, but the chelators can be used for secondary iron overload conditions. | |||
* '''Genetic testing''': Mutational analysis of the ''HFE'' gene mutations, including C282Y and H63D, is particularly useful in patients with a family history (or suspected family history) of hemochromatosis. | |||
* Iron chelation therapy | |||
* | |||
==References== | ==References== | ||
Latest revision as of 18:39, 1 January 2019
|
Hemochromatosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hemochromatosis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Hemochromatosis secondary prevention |
|
Risk calculators and risk factors for Hemochromatosis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sunny Kumar MD [3]
Overview
We can treat hemochromatosis with many options depending on level and cause of increased iron load in body.
Secondary Prevention
Hemochromatosis can be prevented secondarily by:[1][2]
- Dietary modifications: This includes avoidance of excess vitamin C, red meat, iron supplements, and alcohol.
- Phlebotomy: This can be done routinely, typically once every few weeks or months, to prevent iron accumulation.
- Iron chelation therapy: The use of iron chelators is not common for hemochromatosis, but the chelators can be used for secondary iron overload conditions.
- Genetic testing: Mutational analysis of the HFE gene mutations, including C282Y and H63D, is particularly useful in patients with a family history (or suspected family history) of hemochromatosis.
References
- ↑ de Souza AF, Carvalho-Filho RJ, Chebli JF (2001). "[Hereditary hemochromatosis. Case report and review of the literature]". Arq Gastroenterol. 38 (3): 194–202. PMID 11917720.
- ↑ Kew MC (2005). "Prevention of hepatocellular carcinoma". HPB (Oxford). 7 (1): 16–25. doi:10.1080/13651820410024030. PMC 2023918. PMID 18333157.